LUBREX

This brand name is authorized in Nigeria.

Active ingredients

The drug LUBREX contains one active pharmaceutical ingredient (API):

1	Carboxymethylcellulose sodium UNII K679OBS311 - CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED
	Methylcellulose is a chemical compound derived from cellulose. Methylcellulose is used to treat constipation. It is classified as a bulk forming laxative. Methylcellulose is a hydrophilic colloid which absorbs water causing it to swell to a soft gel of uniform consistency. It works by increasing the amount of stool present which improves intestinal contractions.
	Read more about Methylcellulose

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100526	Eye drops	Lubrex Eye Drop SOL_DROPS 0.5% 1 x 10 mL (in LDPE container)	Eye Drops 15 NF-PP-200081 Lubrex Eye Drop Carmellose Sodium BP 0.5 % w/v (Carboxymethyl Cellulose Sodium) Stabilised Oxychloro Complex 0.005% w/v (As Preservative) Water for Injetion BP Active Ingredient: Carboxymethyl Cellulose Sodium Ophthalmic Solution. Excipients: 1. Sodium chlorite 2. Boric Acid 3. Potassium Chloride 4. Sodium Chloride 5. Calcium Chloride Dihydrate 6. Magnesium Chloride Hexahydrate 7. Sodium Hydroxide A4-100526 Drugs Imported Products 1x10ML Prescription Only Medicine (POM) 3/8/2021 MICRO NOVA PHARMACEUTICALS IND. LTD, PLOT 3, BILLINGS WAY, INDUSTRIAL ESTATE, IKEJA IKEJA LAGOS 81299901 solomonsemicrolabs@gmail.com Micro Labs Limited, 92, SIPCOT, HOSUR-635 126, INDIA, India	28/09/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01XA20	Artificial tears and other indifferent preparations	S Sensory organs → S01 Ophthalmologicals → S01X Other ophthalmologicals → S01XA Other ophthalmologicals
Discover more medicines within S01XA20

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100526